Is Remedy Meds legit and worth it?
Remedy Meds is a real GLP-1 telehealth provider; we read its site and scored it 4.0/5 in our independent review (Strong Choice). Biggest plus: Outcome guarantee — the platform stands behind treatment effectiveness. Watch-out: No insurance accepted — full self-pay only.
Scorecard: strongest in Reputation (5.0/5) and Access (4.7/5); weakest in Trust & Transparency (3.5/5) and Support (3.5/5).
Medications
Compounded Semaglutide, Compounded Tirzepatide (as listed on its site, 7 April 2026)
Monthly Cost
$299-$1,399/mo (as listed on its site, 7 April 2026)
Speed to Start
Fast
Prices and medications in this review are as listed on Remedy Meds’s site on 7 April 2026, unless a line is marked otherwise, and have not been re-checked since. Note added 13 October 2026.
Corrected 14 October 2026: this review previously gave a Better Business Bureau rating or listing status. We kept no record of where it came from, so it has been removed. Trustpilot figures in this review are as recorded in April 2026 and have not been re-checked.
Est. 2022
About Remedy Meds
Remedy Meds is a telehealth weight-loss platform founded in 2022 that specializes in compounded semaglutide and tirzepatide prescriptions. The company has quickly scaled into one of the higher-volume GLP-1 providers in the direct-to-consumer space, processing thousands of patients through a streamlined digital onboarding flow. Pricing ranges from 9 to ,399 per month depending on medication type and dosage tier, placing Remedy Meds in the mid-to-upper price bracket among compounded-only providers.
One of Remedy Meds’ standout features is its outcome guarantee, a policy the company advertises prominently. While the specific terms and conditions of this guarantee vary, it signals a level of confidence in their treatment protocols that most competitors do not offer. The onboarding process is notably fast, with many patients reporting prescriptions issued within 24 to 48 hours of completing their intake questionnaire. For patients eager to start treatment without lengthy wait times, this is a genuine advantage.
On Trustpilot, Remedy Meds holds a 4.6-star rating across 11,450+ reviews, which is a strong score at significant volume. Positive reviews frequently cite fast shipping and responsive initial consultations. However, recurring complaints center on billing transparency, auto-renewal charges, and difficulty reaching support after the first prescription is filled. The volume of reviews gives this rating meaningful statistical weight.
This is a pattern we see across several high-volume telehealth providers, but it remains a red flag that prospective patients should weigh carefully. Remedy Meds does not include lab work or access to a registered dietitian in its standard plans, meaning patients will need to coordinate bloodwork and nutritional guidance independently.
Our editorial team finds Remedy Meds to be a capable but imperfect option. The combination of high review volume, an outcome guarantee, and rapid onboarding creates real appeal. However, gaps in ongoing clinical support prevent it from reaching the top tier. Patients who are self-directed and comfortable managing their own health data will get the most out of this platform.
At a Glance
Medications Offered
Compounded Semaglutide, Compounded Tirzepatide (as listed on its site, 7 April 2026)
Compounded
Cost & Insurance
- Monthly: $299-$1,399/mo (as listed on its site, 7 April 2026)
- 6-month estimate: $1,794-$8,394 (as listed on its site, 7 April 2026)
- Insurance: No
- Self-pay: Yes
Clinical Features
- Lab testing: No
- Dietitian access: No
- Pharmacies named: U.S. compounding pharmacies exclusively; four independent quality tests per batch; specific names not disclosed
Delivery & Access
- Format: Subcutaneous
- Nationwide telehealth: Yes
- Speed: Fast
- Spanish-speaking providers: Not stated Corrected 13 October 2026: this line said “Not available”, but our research had recorded it as unknown.
Start your GLP-1 weight loss journey with Remedy Meds today
Medical Disclaimer: This review is for informational purposes only and does not constitute medical advice. GLP-1 medications are prescription drugs that should only be used under the supervision of a licensed healthcare provider. Individual results may vary.
Editorial Independence: GLP-1.Reviews maintains full editorial independence. We read providers’ own pages and public records and publish what we find, with the date we checked.
Corrected 13 October 2026: this review showed a “Verified Provider” badge and said our scores were “based on verified data and standardized criteria”. Neither described a check we had done, so both have been removed.
What the Remedy Meds Intake Looks Like
We walked through Remedy Meds’ “2 minute quiz” ourselves, from the opening “What matters most to you right now?” screen all the way through clinician approval, plan selection, and Apple Pay checkout. The quiz is fast, the safety screens are more thorough than the category average, and the checkout is aggressive.
Strong safety gating. Dedicated screens for eating disorder, suicidal thoughts or history of suicide attempts, end-stage kidney and end-stage liver disease, opioid use (including a “street drugs” option), depression, and alcohol/substance use disorder. Missing a validated PHQ instrument, family history on MTC/MEN2, and a full medication reconciliation.
Low. About 5 minutes, asynchronous clinician review, Apple Pay and Google Pay on checkout, no live video visit required, online clinician visit and overnight shipping bundled free, and a “results or you don’t pay” warranty.
The 9 Stages
Clinical Safety Screens Performed
Remedy Meds is one of the only platforms in our catalog with a dedicated opioid-use screen, and it’s remarkably direct: “Have you taken any opioid medications in the last 3 months?” with three options — No, opiate pain medications, or opiate-based street drugs. Most GLP-1 intakes don’t ask about opioids at all, let alone offer an explicit non-prescription option. Pair that with a separate “alcohol/substance use disorder” option in the medical-history multi-select and an explicit suicidal-thoughts / history-of-attempts gate in the contraindication list, and Remedy is screening for a set of patient-safety signals that the category as a whole tends to wave past.
Remedy’s “Final health check” contraindication multi-select explicitly lists “Have or had an eating disorder (like anorexia or bulimia)” alongside “suicidal thoughts or history of suicide attempts.” Both gates are rare in GLP-1 telehealth intakes despite being clinically relevant — GLP-1 appetite suppression can destabilize restrictive eating patterns, and any appetite/mood medication warrants a baseline suicide risk check. Remedy puts both on screen before any prescription can be issued.
After the eligibility approval, Remedy offers exactly two plans: a Semaglutide Plan at $299/today (labeled “Most Affordable”) and a Tirzepatide Plan at $399/today (labeled “Most Advanced”), both compounded weekly injectables with Forbes Health “Best of 2026 #1 GLP-1” branding. Checkout bundles the online clinician visit ($49 FREE) and overnight FedEx shipping ($19.95 FREE), is FSA/HSA eligible, surfaces Apple Pay and Google Pay, and reframes the $299 as “just $9.97/day.” The plan is flexible month-to-month with no long-term commitment and is backed by the Remedy Warranty — “if it doesn’t work for you, you’re covered.” Patients evaluating Remedy should note that plan selection happens after clinician approval, so the $299 or $399 charge is the first real commitment in the flow.
The quiz captures depression and suicidal-thought gates but does not use a validated PHQ-2 or PHQ-9 depression instrument. MTC/MEN2 was not obviously split out as its own screen in the captured flow — it may be inside the medical-history multi-select continuation — and there is no explicit family history screen for either. There is no full current-medication list beyond the opioid screen, no allergy capture, no blood pressure reading, no ID upload, and no phone OTP. Diet and exercise history are not captured in structured form; the patient’s underlying lifestyle profile is inferred from the goals multi-select and reviewed asynchronously by the clinician.
Source: GLP-1.Reviews editorial walkthrough on April 13, 2026. We completed every screen of the Remedy Meds weight-loss quiz using a representative GLP-1 candidate persona and stopped before submitting any payment information.
Opens remedymeds.com in a new tab. We may earn a commission if you start treatment through this link, at no additional cost to you.
